Prostate Cancer
Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.
September 13, 2023
Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV
September 12, 2023
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
September 12, 2023
Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.
September 12, 2023
Germline Genetic Testing After Cancer Diagnosis.
September 12, 2023
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.
September 12, 2023
Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer.
September 12, 2023
Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer.
September 11, 2023
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
September 11, 2023
Relative search popularity of five advanced prostate cancer medications using Google Trends.
September 11, 2023
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.
September 11, 2023
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.
September 11, 2023
A systematic review evaluating the effectiveness of exercise training on physical condition in prostate cancer patients undergoing androgen deprivation therapy.
September 11, 2023
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T.
September 11, 2023